Medtronic plans new study of blood pressure-lowering device

CHICAGO Feb 17 (Reuters) - Medical device maker Medtronic Plc said on Tuesday it planned to seek approval from U.S. regulators to begin a new study of its version of a hypertension treatment in which nerve connections between the heart and kidney are disrupted.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.